PBPH - Portfolio Building Block World Pharma and Biotech Index ETF
The Portfolio Building Block World Pharma and Biotech Index ETF seeks to provide investors with targeted exposure to the global pharmaceutical and biotechnology industries, two of the most dynamic and innovation-driven sectors in healthcare. The fund seeks to replicate the performance of the BITA Global Pharma and Biotech Select Index, which tracks companies in developed markets that derive a significant portion of their revenue from the discovery, development, and commercialization of human therapeutics.
- Sector
- Healthcare
- Industry
- Biotechnology
- Market Cap
- $11.2M
- Beta
- 0.09
- 52-Week Range
- 24.184-27.47
- Dividend Yield
- $0.02
- IPO Date
- Nov 25, 2025
- Exchange
- NASDAQ
PBPH Options Snapshot
Options pricing data for PBPH is refreshed daily after the close. When listed contracts exist, this page surfaces the latest at-the-money implied volatility, max pain strike, dealer gamma exposure (GEX), and 25-delta skew. Listed contracts and live snapshots appear once the options chain has been published by the exchange for the most recent session.
What This Page Covers
The PBPH overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure.
Frequently asked PBPH overview questions
- What is PBPH?
- PBPH is the ticker symbol for Portfolio Building Block World Pharma and Biotech Index ETF, an listed exchange-traded fund. The Portfolio Building Block World Pharma and Biotech Index ETF seeks to provide investors with targeted exposure to the global pharmaceutical and biotechnology industries, two of the most dynamic and innovation-driven sectors in healthcare. The fund seeks to replicate the performance of the BITA Global Pharma and Biotech Select Index, which tracks companies in developed markets that derive a significant portion of their revenue from the discovery, development, and commercialization of human therapeutics. Listed on NASDAQ. PBPH is the ETF ticker shown on this page; ETF traders use the fund for diversified exposure to its underlying basket, for sector and factor rotation, and for hedging or replication strategies via the listed options chain.
- What are PBPH's key statistics?
- Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) carries a market capitalization of $11.2M, 52-week range of 24.184-27.47. Full holdings disclosure, expense ratio, and tracking-error history live on the per-ticker fundamentals page or the sponsor's site; daily NAV and premium/discount-to-NAV are accessible from the same view. These structural inputs frame how the ETF options market prices implied volatility relative to its constituents.
- What sector or industry does PBPH belong to?
- Portfolio Building Block World Pharma and Biotech Index ETF operates in the Healthcare sector, in the Biotechnology industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare PBPH's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the PBPH data on this page?
- Options snapshots refresh after each trading session; if no snapshot is currently posted for PBPH, it usually reflects low options liquidity or a recently listed name. Fund-level fields (sponsor, expense ratio, holdings concentration where available) refresh from the vendor feed nightly. ETF-specific filings (N-CSR, N-PX, N-CEN) update on the SEC EDGAR cadence. FINRA microstructure data refreshes on the source's cadence; for ETFs the off-exchange volume signal is dominated by authorized-participant creation and redemption rather than directional flow.